Biomedical Career Horizon on Cloudy Side For 1993

While salaries are on the upswing, the number of job opportunities is predicted to decline The coming of a new year, the establishment of a new presidential administration, and some encouraging signs of an economic upturn may yield professional gain for some in the science community. Nevertheless, research directors and human resource managers at United States biomedical research institutions say their approach to the hiring of scientists will remain cautious in 1993. Many add, however, tha

Written byMarcia Clemmitt
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

The coming of a new year, the establishment of a new presidential administration, and some encouraging signs of an economic upturn may yield professional gain for some in the science community. Nevertheless, research directors and human resource managers at United States biomedical research institutions say their approach to the hiring of scientists will remain cautious in 1993.

Many add, however, that though the number of job opportunities in the biomedical field is likely to remain low--as it has been for the past two years--salaries should continue on an upward course. In addition, they point out that scientists in a few specialties- -particularly those combining biology and mathematics--are commanding significantly higher-than-average pay.

"The field as a whole seems relatively flat in terms of hiring and opportunity," says Ames Putnam, vice chairman of the department of education and research at the Mayo Clinic in Rochester, Minn. "Funding is tight. For our part, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies